Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

aTyr Pharma, Inc. (ATYR) Institutional Ownership & Insider Trading

90 institutions reported holding aTyr Pharma, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 6 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ATYRaTyr Pharma, Inc.Follow ATYR — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
16.2M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

90 institutions held 41.4% of the shares. Across filers that reported both quarters, shares held changed -27.5%.

Increased+28New+14Decreased-28Closed-33

Largest moves, shares (millions)

Kalehua Capital Management+3.6MAQR Capital Management+2.1MGsa Capital Partners+1.8MFMR-12.2MBlackRock-4.6MUBS Group AG-2.3M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-3.3Sep 24+7.8Dec 24+6.9Mar 25+4.6Jun 25-5.4Sep 25-6.5Dec 25+3.0Mar 26-15.4Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 269041-27.5%28142833
Mar 2611156+6.2%2330316
Dec 257954-10.7%22142432
Sep 259961-8.2%29272537
Jun 2510866+7.4%24492428
Mar 258662+12.5%35251215
Dec 247755+16.5%2427117
Sep 245548-6.6%1413134

aTyr Pharma, Inc. — questions

Who owns aTyr Pharma, Inc. stock?
90 institutions reported aTyr Pharma, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: FEDERATED HERMES, INC. (8.7%), VANGUARD CAPITAL MANAGEMENT LLC (3.9%), Kalehua Capital Management LLC (3.6%).
Are aTyr Pharma, Inc. insiders buying or selling?
6 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from aTyr Pharma, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.